Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
-
KIGALI, Rwanda and SAN FRANCISCO, June 15, 2026 (GLOBE NEWSWIRE) -- Bio Usawa, a biotechnology company dedicated to expanding access to high-quality biologic medicines across Africa, today announced...
-
OAKLAND, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biosphere, a U.S.-based pioneer in biomanufacturing technology, today announced the award of an Other Transaction Authority (OTA) agreement with a...
-
TORONTO, Ontario and HAIFA, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biopharmaceutical company...
-
ZymoChem has demonstrated that its bio-based and biodegradable SAP matches and surpasses the performance of conventional petroleum-based materials.
-
Laupheim (Germany), Milford, MA (USA), March 24, 2026 (GLOBE NEWSWIRE) -- Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion Milford,...
-
Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering.The Asset Purchase...
-
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply...
-
Dr. Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology, and production automation, effective April 1,...